HLA-C and neoplasm: In addition, other epigenetic drugs including DNA methyltransferase inhibitors (e.g., 5‐azacytidine; NCT02260440) and histone deacetylase inhibitors (e.g., entinostat; NCT02437136), can reactivate silenced MHC genes and enhance tumour antigen presentation.